Correlation between HBV protein preS2 and tumor markers of hepatocellular carcinoma.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Pathology, Research and Practice

• Publication date

  2017-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.prp.2017.08.007PMID 28869105
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• GPC-3 in hepatocellular carcinoma: current perspectives

  2016cited by this paper
• HBV preS2 transactivates FOXP3 expression in malignant hepatocytes

  2015cited by this paper
• Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability.

  2015cited by this paper
• Gene expression analysis for evaluation of potential biomarkers in hepatocellular carcinoma.

  2015cited by this paper
• Chronic hepatitis B virus and hepatitis C virus infections and cancer: synergy between viral and host factors.

  2015cited by this paper
• HBV preS2 promotes the expression of TAZ via miRNA-338-3p to enhance the tumorigenesis of hepatocellular carcinoma

  2015cited by this paper
• Reduced nucleic ZHX2 involves in oncogenic activation of glypican 3 in human hepatocellular carcinoma.

  2014cited by this paper
• Glypican-3 and Alphafetoprotein as Diagnostic Tests for Hepatocellular Carcinoma

  2012cited by this paper
• Zinc fingers and homeoboxes 2 inhibits hepatocellular carcinoma cell proliferation and represses expression of Cyclins A and E.

  2012cited by this paper
• Scoring of p16INK4a immunohistochemistry based on independent nuclear staining alone can sufficiently distinguish between endocervical and endometrial adenocarcinomas in a tissue microarray study

  2009cited by this paper
• Hepatitis B virus protein preS2 potentially promotes HCC development via its transcriptional activation of hTERT

  2009cited by this paper
• ZHX2 is a repressor of α-fetoprotein expression in human hepatoma cell lines

  2008cited by this paper
• Nuclear Receptor Interaction Protein (NRIP) expression assay using human tissue microarray and immunohistochemistry technology confirming nuclear localization

  2008cited by this paper
• Hepatitis B virus integration, fragile sites, and hepatocarcinogenesis.

  2007cited by this paper
• Alteration of Gene Expression in Human Hepatocellular Carcinoma with Integrated Hepatitis B Virus DNA

  2005cited by this paper
• Novel Autoregulatory Function of Hepatitis B Virus M Protein on Surface Gene Expression*

  2005cited by this paper
• Primary liver cancer: worldwide incidence and trends.

  2004cited by this paper
• Hepatitis B virus-related insertional mutagenesis occurs frequently in human liver cancers and recurrently targets human telomerase gene

  2003cited by this paper
• Immunohistochemical Staining in the Distinction Between Primary Endometrial and Endocervical Adenocarcinomas: Another Viewpoint

  2002cited by this paper
• The preS2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator

  1990cited by this paper
• Serum alphafetoprotein levels in subjects infected with hepatitis B virus

  1988cited by this paper
• Primary carcinoma of the liver. A study of 100 cases among 48,900 necropsies

  1954cited by this paper

• Detection of serum large and middle hepatitis B virus surface proteins: A novel potential diagnostic and prognostic biomarker for chronic hepatitis B.

  2023cites this paper
• Pathogenicity and virulence of Hepatitis B virus

  2022cites this paper
• An Increase in the Levels of Middle Surface Antigen Characterizes Patients Developing HBV-Driven Liver Cancer Despite Prolonged Virological Suppression

  2021cites this paper
• Hepatitis B Virus preS2 Domain Promotes Angiogenesis in Hepatocellular Carcinoma via Transcriptional Activation of VEGFA Promoter

  2021influential citation
• Hepatitis B virus X protein upregulates alpha‐fetoprotein to promote hepatocellular carcinoma by targeting miR‐1236 and miR‐329

  2020influential citation
• Mechanisms and immunotherapies of HBV- and NAFLD-related hepatocellular carcinoma

  2020influential citation
• Enigmatic PreS deletions in hepatitis B virus DNA

  2020influential citation
• Pre-S 2 and HBV associated hepatocellular carcinoma

  2018cites this paper